Form 4 for LION Lionsgate Studios Corp.
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-09 · accession 0000950170-25-070852 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-13 | 2025-05-09 | LION | FELTHEIMER JON | CEO, Dir | J - Other | $0.00 | +1.02M | 3.01M | +51% | $0 |
| DM | 2025-05-13 | 2025-05-09 | LION | FELTHEIMER JON | CEO, Dir | J - Other | $0.00 | +4.58M | 556.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-05-09 | J | A | 1,016,589 | $0.00 | 3,013,260 | D | — | — | (F1) On May 6, 2025, in connection with the consummation of the transactions contemplated by the Arrangement Agreement, dated as of January 29, 2025, as amended by an amending agreement dated March 12, 2025, by and among the Issuer (f/k/a Lionsgate Studios Holding Corp.), Lions Gate Entertainment Corp. ("LGEC"), LG Sirius Holdings ULC and Lionsgate Studios Holding Corp. (f/k/a Lionsgate Studios Corp.), each equity award outstanding under the equity plans of LGEC held by a LGEC service provider who will be a service provider of Issuer after the transactions were converted into an award of Issuer under the New Lionsgate 2025 Plan (as defined in the Issuer's joint proxy statement/prospectus included in the Registration Statement on Form S-4), on a basis that is intended to preserve the fair market value of such awards immediately before and immediately after the conversion. (F2) Amount includes the following restricted share units ("RSUs") granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 95,388 RSUs scheduled to vest on July 27, 2025; (ii) 393,805 RSUs scheduled to vest in two equal annual installments on July 3, 2025 and 2026; and (iii) 527,396 RSUs scheduled to vest in three equal annual installments on July 1, 2025, 2026 and 2027. |
| 2 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 556,730 | $0.00 | 556,730 | D | $24.98 · — to 2026-10-11 | 556,730 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 3 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 623,235 | $0.00 | 623,235 | D | $23.09 · — to 2026-10-11 | 623,235 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 4 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 623,235 | $0.00 | 623,235 | D | $18.47 · — to 2026-10-11 | 623,235 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 5 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 123,162 | $0.00 | 123,162 | D | $23.37 · — to 2028-06-07 | 123,162 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 6 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 123,162 | $0.00 | 123,162 | D | $29.21 · — to 2028-06-07 | 123,162 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 7 | Derivative | Share Appreciation Right | 2025-05-09 | J | A | 1,970,600 | $0.00 | 1,970,600 | D | $8.30 · — to 2030-08-21 | 1,970,600 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |
| 8 | Derivative | Non-qualified stock option (right to buy) | 2025-05-09 | J | A | 556,730 | $0.00 | 556,730 | D | $19.99 · — to 2026-10-11 | 556,730 Common Shares | (F3) Fully vested and exercisable as of the date hereof. |